Revenue
-
Net Income
-$106.2M
▼ 22.2% YoY
EPS
$-1.76
▼ 0.6% YoY
Cash
$59.5M
▲ 87.8% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Kilroy Conor See Remarks | Sell | Apr 16, 2026 | 11.7K | $7.02 | $82K | Form 4 ↗ |
Kilroy Conor See Remarks | Grant | Mar 2, 2026 | 62.3K | $0.00 | $0 | Form 4 ↗ |
Gibney Anthony S See Remarks | Grant | Mar 2, 2026 | 71.2K | $0.00 | $0 | Form 4 ↗ |
de los Pinos Elisabet See Remarks | Grant | Mar 2, 2026 | 166.0K | $0.00 | $0 | Form 4 ↗ |
Plavsic Mark Chief Technology Officer | Grant | Mar 2, 2026 | 62.3K | $0.00 | $0 | Form 4 ↗ |
Hopkins Janet Jill Chief Medical Officer | Grant | Mar 2, 2026 | 89.1K | $0.00 | $0 | Form 4 ↗ |
Elazzouzi Amy Senior Vice President, Finance | Grant | Mar 2, 2026 | 44.5K | $0.00 | $0 | Form 4 ↗ |
Kilroy Conor See Remarks | Sell | Feb 17, 2026 | 12.1K | $5.05 | $61K | Form 4 ↗ |
Plavsic Mark Chief Technology Officer | Sell | Feb 17, 2026 | 15.9K | $5.05 | $80K | Form 4 ↗ |
Hopkins Janet Jill Chief Medical Officer | Sell | Feb 17, 2026 | 20.4K | $5.06 | $103K | Form 4 ↗ |
Elazzouzi Amy Senior Vice President, Finance | Sell | Feb 17, 2026 | 8.5K | $5.06 | $43K | Form 4 ↗ |
de los Pinos Elisabet See Remarks | Sell | Feb 17, 2026 | 47.6K | $5.06 | $241K | Form 4 ↗ |